Post by Pfaff Medical GmbH

🔬 New clinical study confirms the value of Bilimeter 3D in neonatal POCT bilirubin testing A recently published clinical study demonstrates that bilirubin measurement using the Bilimeter 3D spectrophotometric Point‑of‑Care system shows a very high level of agreement with laboratory reference methods — delivered directly at the bedside. ✅ Higher accuracy than transcutaneous screening methods ✅ Results available within minutes ✅ Minimal blood volume required (30 µL capillary sample) ✅ Supports fast clinical decisions and efficient neonatal workflows 📘 Published in: Bratislava Medical Journal (2026) 📄 Title: Comparisons of Optimal Point‑of‑Care Bilirubin Testing for Accuracy 🔎 DOI: 10.1007/s44411-026-00585-3 A strong signal for the growing role of advanced POCT solutions in neonatology. #Bilimeter3D #POCT #Neonatology #MedTech #Bilirubin #ClinicalEvidence #HealthcareInnovation #Pfaffmedical